CD44 variant 9 is a potential biomarker of tumor initiating cells predicting survival outcome in hepatitis C virus-positive patients with resected hepatocellular carcinoma

Anna Kakehashi, Naomi Ishii, Eiji Sugihara, Min Gi, Hideyuki Saya, Hideki Wanibuchi

Research output: Contribution to journalArticle

19 Citations (Scopus)

Fingerprint Dive into the research topics of 'CD44 variant 9 is a potential biomarker of tumor initiating cells predicting survival outcome in hepatitis C virus-positive patients with resected hepatocellular carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences